中医药调控肠道菌群-短链脂肪酸轴管理2型糖尿病综述
2型糖尿病(T2DM)是全球流行慢性代谢病,肠道菌群(GM)与短链脂肪酸(SCFA)轴紊乱是其核心病理机制之一。本文系统综述中医药通过多靶点整体调节干预GM-SCFA轴的应用,涵盖中药复方、中成药、单味药、单体成分及推拿、针灸等疗法。
要点
- GM-SCFA轴紊乱通过能量代谢障碍、胰岛素抵抗等机制参与T2DM。
- 中药复方如左归降糖清肝方、葛根芩连汤可调控GM-SCFA轴。
- 中成药、单味药、单体成分及推拿针灸等疗法亦显示调控潜力。
核心结论
- 中医药通过整体调节和多靶点干预精准调控GM-SCFA轴,为T2DM防治提供新策略。
研究设计与样本
- 系统综述,检索PubMed、Google Scholar和Web of Science近十年文献,关键词包括TCM、GM、SCFAs和T2DM。
主要发现
- GM-SCFA轴紊乱通过能量代谢障碍、胰岛素抵抗、肠道屏障受损、慢性低度炎症激活、胆汁酸代谢异常调控及肠-胰轴和肠-脑轴信号紊乱诱导T2DM。
- 中医药调控GM-SCFA轴的应用涵盖中药复方、中成药、单味中药、中药单体成分及其他中医疗法(如推拿、针灸)。
临床怎么用
- 临床可考虑将中药复方、中成药、单味药、单体成分及推拿、针灸等作为调控GM-SCFA轴以管理T2DM的干预选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Type 2 diabetes mellitus (T2DM), a globally prevalent chronic metabolic disorder, imposes a significant worldwide public health burden. As a vital "microbial organ" within the human body, the balance of the gut microbiota (GM) structure and function is crucial for maintaining host metabolic health. Short-chain fatty acids (SCFAs), the metabolic products of GM, serve as key signaling molecules that play central roles in maintaining intestinal homeostasis, regulating systemic energy metabolism, and improving insulin sensitivity. Dysregulation of the "GM-SCFA axis" has emerged as a core pathological mechanism in the onset and progression of T2DM. Traditional Chinese Medicine (TCM) possesses unique advantages in T2DM treatment through its "holistic regulation and multi-targeted intervention," which enables precise modulation of the GM-SCFA axis. This paper provides a systematic review of the pathological mechanisms by which dysregulation of the GM-SCFA axis induces T2DM, and specifically covers energy metabolism disorders, insulin resistance, intestinal barrier impairment, chronic low-grade inflammatory activation, abnormal bile acid metabolism regulation, and disrupted gut-pancreatic axis and gut-brain axis signaling. Using keywords such as TCM, GM, SCFAs, and T2DM, we conducted an extensive literature search across databases including PubMed, Google Scholar, and Web of Science for publications from the past decade. This systematic review examines the application of TCM in regulating the "GM-SCFA axis" from multiple perspectives: Chinese herbal compounds (e.g., Zuogui Jiangtang Qinggan Formula, Gegen Qinlian Decoction), Chinese patent medicines (e.g., Shouhui Tongbian Capsules, Compound Danshen Dripping Pills), single-herb Chinese medicines (e.g., Edgeworthia gardneri, Alpinia oxyphylla), single-component compounds from TCM (e.g., Cyclocarya paliurus polysaccharide, Achyranthes bidentata polysaccharide water-soluble 1), and other TCM therapies (e.g., tuina, acupuncture). This study aims to systematically explore the mechanisms by which dysregulation of the "GM-SCFA axis" induces T2DM while providing novel therapeutic strategies for T2DM prevention and treatment using TCM. It also seeks to establish scientific foundations for developing novel TCM intervention strategies targeting the "GM-SCFA axis" in T2DM management.
引用
- Yang R, Zhou Y, Shen Y, et al. Regulation of Traditional Chinese Medicine Gut Microbiota Short-Chain Fatty Acid Axis in Type 2 Diabetes Management: A Review. Am J Chin Med. 2026. PMID: 41582084. doi:10.1142/S0192415X26500011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。